Cargando…

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression

PURPOSE: According to the 2015 American Geriatrics Society (AGS) Beers criteria, most antipsychotics are inappropriate in Parkinson’s disease (PD) patients due to the risk of worsening Parkinsonian symptoms. This study examined the incidence and predictors of inappropriate antipsychotic use among lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chekani, Farid, Holmes, Holly M, Johnson, Michael L, Chen, Hua, Sherer, Jeffrey T, Aparasu, Rajender R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999551/ https://www.ncbi.nlm.nih.gov/pubmed/32099480 http://dx.doi.org/10.2147/DHPS.S226486

Ejemplares similares

Antipsychotic Use and Risk of Nursing Home Admission Among Dual-Eligible Medicare Beneficiaries: A Propensity-Matched Study
por: Aparasu, Rajender R., et al.
Publicado: (2015)

Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder
por: Seo, Rubo J., et al.
Publicado: (2010)

Use of antipsychotics and long-term risk of parkinsonism
por: d’Errico, Angelo, et al.
Publicado: (2021)

Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatment
por: Khandker, Rezaul, et al.
Publicado: (2022)

Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report
por: Baune, Bernhard T, et al.
Publicado: (2010)

Atypical antipsychotics as add-on treatment in late-life depression
por: Cakir, Sibel, et al.
Publicado: (2016)

The impact of antipsychotic adherence on acute care utilization
por: Perkins, Anthony J., et al.
Publicado: (2023)

Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study
por: Yuan, Mei, et al.
Publicado: (2017)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2012)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
por: O’Day, Ken, et al.
Publicado: (2013)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
por: Zhang, Han, et al.
Publicado: (2019)

Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults
por: Amodeo, Katherine, et al.
Publicado: (2016)

Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
por: Gazzellone, Matthew J., et al.
Publicado: (2022)

Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes
por: Khandker, Rezaul, et al.
Publicado: (2022)

PM441. Long term atypical antipsychotic treatment improves cognitive performance in schizophrenia but not surpassing conventional antipsychotic drugs effects.
por: Vera, Gabriel Selva, et al.
Publicado: (2016)

Associated mortality risk of atypical antipsychotic medication in individuals with dementia
por: Phiri, Peter, et al.
Publicado: (2022)

Quality improvement in resident education: a pilot project to mitigate metabolic side effects from atypical antipsychotic medications in youth
por: Jeffrey, Jessica
Publicado: (2015)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

How do we define high and low dose intensity of heart failure medications: a scoping review
por: Kwak, Min Ji, et al.
Publicado: (2023)

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
por: Nadkarni, Anagha, et al.
Publicado: (2013)

Atypical antipsychotics and delirium in critical care
por: Wise, Matt P, et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Constrictive Pericarditis Associated with Atypical Antipsychotics
por: Chen, Kuan-chin Jean, et al.
Publicado: (2012)

Pedal edema associated with atypical antipsychotics
por: Munshi, Santanu, et al.
Publicado: (2016)

Predictors of Effect of Atypical Antipsychotics on Speech
por: Sinha, Preeti, et al.
Publicado: (2015)

Clinical pharmacology of atypical antipsychotics: an update
por: Mauri, M.C., et al.
Publicado: (2014)

Anti-stress Properties of Atypical Antipsychotics
por: Sanson, Alice, et al.
Publicado: (2020)

Pain management practices for outpatients with breast cancer
por: Talwar, Ashna, et al.
Publicado: (2022)

Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis
por: Kadakia, Aditi, et al.
Publicado: (2021)

Long-Acting Atypical Antipsychotics: Characterization of the Local Tissue Response
por: Paquette, Sara Montminy, et al.
Publicado: (2014)

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
por: Toja-Camba, Francisco José, et al.
Publicado: (2021)

Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study
por: Yu, Wenjuan, et al.
Publicado: (2021)

Refractory dry eye disease associated with Meige’s syndrome induced by long-term use of an atypical antipsychotic
por: Kim, Ji Eun, et al.
Publicado: (2020)

Gender differences in the use of atypical antipsychotic medications for ICU delirium
por: Karamchandani, Kunal, et al.
Publicado: (2018)

Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
por: Broekema, W. J., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_po57mnhvgeu8srcej5vv3rqcap